1. Market – Executive Summary

2. Market Overview

    2.1. Market Definition and Introduction

    2.2. Market Taxonomy/ Research Scope

3. Market Background and Foundation Data

    3.1. Global Chemical Industry Overview

    3.2. Carglumic Acid: Production Method Overview

    3.3. Carglumic Acid: Application Mapping

    3.4. Carglumic Acid: Apparent Production & Consumption Analysis

        3.4.1. Production Capacity (Kilo Tons)

            3.4.1.1. By Key Regions

            3.4.1.2. By Key Companies

        3.4.2. Consumption Statistics

        3.4.3. Apparent Trade Analysis

    3.5. Global Pharmaceutical Industry Outlook

    3.6. Global Orphan Drug Market Outlook

    3.7. Market Opportunity Assessment

        3.7.1. Total Available Market (US$ million)

        3.7.2. Serviceable Addressable Market (US$ million)

        3.7.3. Serviceable Obtainable Market (US$ million)

    3.8. Market Dynamics

        3.8.1. Market Growth Drivers

        3.8.2. Market Restraints

        3.8.3. Market Opportunity

        3.8.4. Market Trends

    3.9. Industry Value and Supply Chain Analysis

        3.9.1. Value Added at Each Node of Supply Chain

        3.9.2. Gross Profitability Margins (at Every Level)

        3.9.3. List of Key Participants

            3.9.3.1. Key Manufacturers

            3.9.3.2. Key Distributor/Retailers

            3.9.3.3. Key Buyers

    3.10. Forecast Factors – Relevance and Impact

    3.11. Macro-Economic Factors

    3.12. PESTLE Analysis

    3.13. Porter’s Five Force Analysis

    3.14. Investment Feasibility Analysis

4. Global Demand (Tons) Analysis and Forecast

    4.1. Historical Market Volume (Tons) Analysis, 2018-2022

    4.2. Current and Future Market Volume (Tons) Projections, 2023-2033

    4.3. Y-o-Y Volume Growth Trend Analysis

5. Global Market – Pricing Analysis

    5.1. Dosage and Country-Level Pricing Analysis

    5.2. Global Average Pricing Analysis Benchmark

    5.3. Factors Influencing Pricing

6. Global Market Value (US$ million) Analysis and Forecast

    6.1. Historical Market Value (US$ million) Analysis, 2018-2022

    6.2. Current and Future Market Value (US$ million) Projections, 2023-2033

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Market Analysis and Forecast, By Dosage

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ million) and Volume (Tons) Analysis By Dosage, 2018-2022

    7.3. Current and Future Market Size (US$ million) Analysis and Volume (Tons) Forecast By Dosage, 2023-2033

        7.3.1. Dispersible Tablets

        7.3.2. Oral Disintegrating Tablets

        7.3.3. Others

    7.4. Market Attractiveness Analysis By Dosage

8. Global Market Analysis and Forecast, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ million) and Volume (Tons) Analysis By Distribution Channel, 2018-2022

    8.3. Current and Future Market Size (US$ million) Analysis and Volume (Tons) Forecast By Distribution Channel, 2023-2033

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. E-Commerce

    8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Market Analysis and Forecast, By Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ million) and Volume (Tons) Analysis By Region, 2018-2022

    9.3. Current Market Size (US$ million) Analysis and Volume (Tons) Forecast By Region, 2023-2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East & Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis and Forecast

    10.1. Introduction / Key Findings

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    10.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Dosage

        10.4.3. By Distribution Channel

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Dosage

        10.5.3. By Distribution Channel

11. Latin America Market Analysis and Forecast

    11.1. Introduction / Key Findings

    11.2. Pricing Analysis

    11.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    11.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Argentina

            11.4.1.4. Rest of Latin America

        11.4.2. By Dosage

        11.4.3. By Distribution Channel

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Dosage

        11.5.3. By Distribution Channel

12. Europe Market Analysis and Forecast

    12.1. Introduction / Key Findings

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    12.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. Italy

            12.4.1.4. Spain

            12.4.1.5. U.K.

            12.4.1.6. BENELUX

            12.4.1.7. Russia

            12.4.1.8. Rest of Europe

        12.4.2. By Dosage

        12.4.3. By Distribution Channel

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Dosage

        12.5.3. By Distribution Channel

13. East Asia Market Analysis and Forecast

    13.1. Introduction / Key Findings

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    13.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

        13.4.2. By Dosage

        13.4.3. By Distribution Channel

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Dosage

        13.5.3. By Distribution Channel

14. South Asia & Oceania Market Analysis and Forecast

    14.1. Introduction / Key Findings

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    14.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        14.4.1. By Country

            14.4.1.1. India

            14.4.1.2. Thailand

            14.4.1.3. Indonesia

            14.4.1.4. Malaysia

            14.4.1.5. Australia & New Zealand

            14.4.1.6. Rest of South Asia & Oceania

        14.4.2. By Dosage

        14.4.3. By Distribution Channel

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Dosage

        14.5.3. By Distribution Channel

15. Middle East & Africa Market Analysis and Forecast

    15.1. Introduction / Key Findings

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ million) and Volume (Tons) Trend Analysis By Market Taxonomy, 2018-2022

    15.4. Market Size (US$ million) and Volume (Tons) Forecast By Market Taxonomy, 2023-2033

        15.4.1. By Country

            15.4.1.1. GCC Countries

            15.4.1.2. South Africa

            15.4.1.3. Northern Africa

            15.4.1.4. Turkiye

            15.4.1.5. Rest of Middle East & Africa

        15.4.2. By Dosage

        15.4.3. By Distribution Channel

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Dosage

        15.5.3. By Distribution Channel

16. Country-level Market Analysis and Forecast

    16.1. Introduction / Key Findings

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. US Market Analysis

        16.2.1. Value Proportion Analysis By Market Taxonomy

        16.2.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.2.2.1. By Dosage

            16.2.2.2. By Distribution Channel

    16.3. Canada Market Analysis

        16.3.1. Value Proportion Analysis By Market Taxonomy

        16.3.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.3.2.1. By Dosage

            16.3.2.2. By Distribution Channel

    16.4. Brazil Market Analysis

        16.4.1. Value Proportion Analysis By Market Taxonomy

        16.4.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.4.2.1. By Dosage

            16.4.2.2. By Distribution Channel

    16.5. Mexico Market Analysis

        16.5.1. Value Proportion Analysis By Market Taxonomy

        16.5.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.5.2.1. By Dosage

            16.5.2.2. By Distribution Channel

    16.6. Argentina Market Analysis

        16.6.1. Value Proportion Analysis By Market Taxonomy

        16.6.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.6.2.1. By Dosage

            16.6.2.2. By Distribution Channel

    16.7. Germany Car glumic Acid Market Analysis

        16.7.1. Value Proportion Analysis By Market Taxonomy

        16.7.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.7.2.1. By Dosage

            16.7.2.2. By Distribution Channel

    16.8. France Market Analysis

        16.8.1. Value Proportion Analysis By Market Taxonomy

        16.8.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.8.2.1. By Dosage

            16.8.2.2. By Distribution Channel

    16.9. Italy Market Analysis

        16.9.1. Value Proportion Analysis By Market Taxonomy

        16.9.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.9.2.1. By Dosage

            16.9.2.2. By Distribution Channel

    16.10. Spain Market Analysis

        16.10.1. Value Proportion Analysis By Market Taxonomy

        16.10.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.10.2.1. By Dosage

            16.10.2.2. By Distribution Channel

    16.11. BENELUX Market Analysis

        16.11.1. Value Proportion Analysis By Market Taxonomy

        16.11.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.11.2.1. By Dosage

            16.11.2.2. By Distribution Channel

    16.12. Russia Market Analysis

        16.12.1. Value Proportion Analysis By Market Taxonomy

        16.12.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.12.2.1. By Dosage

            16.12.2.2. By Distribution Channel

    16.13. U.K. Market Analysis

        16.13.1. Value Proportion Analysis By Market Taxonomy

        16.13.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.13.2.1. By Dosage

            16.13.2.2. By Distribution Channel

    16.14. China Market Analysis

        16.14.1. Value Proportion Analysis By Market Taxonomy

        16.14.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.14.2.1. By Dosage

            16.14.2.2. By Distribution Channel

    16.15. Japan Market Analysis

        16.15.1. Value Proportion Analysis By Market Taxonomy

        16.15.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.15.2.1. By Dosage

            16.15.2.2. By Distribution Channel

    16.16. South Korea Market Analysis

        16.16.1. Value Proportion Analysis By Market Taxonomy

        16.16.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.16.2.1. By Dosage

            16.16.2.2. By Distribution Channel

    16.17. India Market Analysis

        16.17.1. Value Proportion Analysis By Market Taxonomy

        16.17.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.17.2.1. By Dosage

            16.17.2.2. By Distribution Channel

    16.18. ASEAN Countries Market Analysis

        16.18.1. Value Proportion Analysis By Market Taxonomy

        16.18.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.18.2.1. By Dosage

            16.18.2.2. By Distribution Channel

    16.19. Australia Market Analysis

        16.19.1. Value Proportion Analysis By Market Taxonomy

        16.19.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.19.2.1. By Dosage

            16.19.2.2. By Distribution Channel

    16.20. GCC Countries Market Analysis

        16.20.1. Value Proportion Analysis By Market Taxonomy

        16.20.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.20.2.1. By Dosage

            16.20.2.2. By Distribution Channel

    16.21. Turkiye Market Analysis

        16.21.1. Value Proportion Analysis By Market Taxonomy

        16.21.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.21.2.1. By Dosage

            16.21.2.2. By Distribution Channel

    16.22. South Africa Market Analysis

        16.22.1. Value Proportion Analysis By Market Taxonomy

        16.22.2. Volume (Tons) and Value (US$ million) Analysis and Forecast By Market Taxonomy, 2018-2033

            16.22.2.1. By Dosage

            16.22.2.2. By Distribution Channel

17. Market Structure Analysis

    17.1. Market Analysis By Tier of Companies

    17.2. Market Concentration of Players

    17.3. Market Share Analysis of Top Players

    17.4. Market Presence Analysis

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking of Products

    18.3. Competition Deep Dive:

        18.3.1. Apothecon Pharmaceuticals Pvt Ltd

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Key Financials

            18.3.1.4. Sales Footprint

            18.3.1.5. SWOT Analysis

            18.3.1.6. Key Developments

            18.3.1.7. Strategy Overview

        18.3.2. Manus Aktteva Biopharma LLP

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Key Financials

            18.3.2.4. Sales Footprint

            18.3.2.5. SWOT Analysis

            18.3.2.6. Key Developments

            18.3.2.7. Strategy Overview

        18.3.3. Civentichem LLC

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Key Financials

            18.3.3.4. Sales Footprint

            18.3.3.5. SWOT Analysis

            18.3.3.6. Key Developments

            18.3.3.7. Strategy Overview

        18.3.4. Dipharma Francis S.r.l

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Key Financials

            18.3.4.4. Sales Footprint

            18.3.4.5. SWOT Analysis

            18.3.4.6. Key Developments

            18.3.4.7. Strategy Overview

        18.3.5. Phillips Limited.

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Key Financials

            18.3.5.4. Sales Footprint

            18.3.5.5. SWOT Analysis

            18.3.5.6. Key Developments

            18.3.5.7. Strategy Overview

        18.3.6. Recordati Rare Diseases

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Key Financials

            18.3.6.4. Sales Footprint

            18.3.6.5. SWOT Analysis

            18.3.6.6. Key Developments

            18.3.6.7. Strategy Overview

        18.3.7. Other Prominent Player’s

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio

            18.3.7.3. Key Financials

            18.3.7.4. Sales Footprint

            18.3.7.5. SWOT Analysis

            18.3.7.6. Key Developments

            18.3.7.7. Strategy Overview

19. Assumptions & Acronyms Used

20. Research Methodology

※参考情報 カルグルミン酸は、主に遺伝性の尿素サイクル障害を治療するために用いられる医薬品です。尿素サイクル障害は、肝臓でのアンモニアの代謝に関与する酵素の欠乏や異常によって引き起こされる病気で、これにより体内にアンモニアが蓄積し、重篤な神経障害や死亡につながることがあります。カルグルミン酸は、オルニチンカルバモイルトランスフェラーゼ（OTC）欠損症の患者に特に有効です。 カルグルミン酸は、体内でバリンとロイシンを代謝する過程において重要な役割を果たし、こうしたアミノ酸を利用して尿素を生成させる効果があります。このため、カルグルミン酸を投与することで、尿素サイクルの機能が改善され、アンモニアのレベルを下げることが期待されます。カルグルミン酸は、経口または注射の形で提供され、使用方法や用量は患者の状態や医師の指示に基づいて決定されます。 カルグルミン酸の効果についての研究は、多くの症例スタディや臨床試験を通じて行われてきました。特に新生児や幼児の尿素サイクル障害の治療に関するデータが多く、早期に治療を行うことで、発育や生活の質を向上させることが示されています。また、成人患者においても、症状の軽減や生活の質の向上が確認されています。 カルグルミン酸の使用は、尿素サイクル障害における唯一の治療法ではなく、食事療法や他の薬剤と併用されることが一般的です。食事療法には、低蛋白質の食品を選択することで、体内でのアンモニア生成を抑えることが含まれます。また、他の医薬品、たとえば、アミノ酸製剤やアンモニウムの排泄を促す薬剤が併用されることで、より効果的な治療が実現します。 カルグルミン酸の関連技術としては、遺伝子治療や細胞治療の研究が進展しています。これらの技術は、尿素サイクル障害の根本的な治療法として期待されています。遺伝子治療は、病気の原因となる遺伝子を修正または置換することで、正常な酵素活性を回復させることを目的としています。一方で、細胞治療は、正常な肝臓の機能を持つ細胞を移植することで、尿素サイクルを適切に機能させることを試みています。 さらに、カルグルミン酸は、特定のアミノ酸や代謝関連の疾患に対する新しい治療法の開発にも寄与しています。これにより、さまざまな代謝異常に関連する病気の治療戦略が広がることが期待されています。 カルグルミン酸の使用にあたっては、副作用や禁忌も考慮する必要があります。一般的には、安全性が高いとされていますが、場合によっては過敏症や消化不良などの軽微な副作用が報告されています。特に、他の薬剤と併用する際には相互作用に注意が必要です。 今後の研究では、カルグルミン酸の効果をさらに高めるための新しい治療法や、患者にとってより安全で効率的な治療法の確立が求められています。また、早期の診断技術の向上により、尿素サイクル障害を持つ患者の治療がより効果的に行えることも期待されています。 このように、カルグルミン酸は尿素サイクル障害の治療において非常に重要な役割を果たしており、今後の医療分野における研究開発においても注目され続けるでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/